Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation

Journal of Gastrointestinal Cancer

Volumn 42, Issue 1, 2011, Pages 50-53

  Kim, Richard ^a   Aucejo, Federico ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Sirolimus and hepatocellular carcinoma; Sorafenib

Indexed keywords

MYCOPHENOLIC ACID; RAPAMYCIN; SORAFENIB; TACROLIMUS;

ADULT; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG POTENTIATION; FATIGUE; HAND FOOT SYNDROME; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; REVIEW;

BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEIN KINASE INHIBITORS; PYRIDINES; SIROLIMUS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79952538041     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9196-2     Document Type: Review

References (11)

1. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti F Montalto, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 1:STN:280:DyaK287nsFWltw%3D%3D 10.1056/NEJM199603143341104 8594428 (Pubitemid 26079803)
2. H Kirimlioglu I Dvorchick K Ruppert S Finkelstein JW Marsh S Iwatsuki A Bonham, et al. 2001 Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications Hepatology 34 502 510 1:STN:280:DC%2BD3Mvot1yltA%3D%3D 10.1053/jhep.2001.26633 11526535 (Pubitemid 32786640)
3. J Zhou Z Wang ZQ Wu SJ Qiu Y Yu XW Huang ZY Tang, et al. 2008 Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria Transplant Proc 40 3548 3553 1:STN:280:DC%2BD1M%2Fkt12qsw%3D%3D 10.1016/j.transproceed.2008.03.165 19100435
4. MA Zimmerman JF Trotter M Wachs T Bak J Campsen A Skibba I Kam 2008 Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma Liver Transplant 14 633 638 10.1002/lt.21420 (Pubitemid 351696274)
5. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008;135:1972-1983, 1983 e1971-1911.
6. AL Cheng YK Kang Z Chen CJ Tsao S Qin JS Kim R Luo, et al. 2009 Efficacy and safety of sorafenib in patients in the Asia Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25 34 1:CAS:528:DC%2BD1cXhsFChtbnM 10.1016/S1470-2045(08)70285-7 19095497
7. JM Llovet S Ricci V Mazzaferro P Hilgard E Gane JF Blanc AC de Oliveira, et al. 2008 Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 1:CAS:528:DC%2BD1cXovFWjsL8%3D 10.1056/NEJMoa0708857 18650514
8. P Newell S Toffanin A Villanueva DY Chiang B Minguez L Cabellos R Savic, et al. 2009 Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo J Hepatol 51 725 733 1:CAS:528:DC%2BD1MXhtFagt77O 10.1016/j.jhep.2009.03.028 19665249
9. Z Wang J Zhou J Fan SJ Qiu Y Yu XW Huang ZY Tang 2008 Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma Clin Cancer Res 14 5124 5130 1:CAS:528: DC%2BD1cXpslKgtLc%3D 10.1158/1078-0432.CCR-07-4774 18698030
10. JD Hainsworth DR Spigel HA Burris 3rd D Waterhouse BL Clark R Whorf 2010 Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma J Clin Oncol 28 2131 2136 1:CAS:528:DC%2BC3cXpsFSgsb4%3D 10.1200/JCO.2009.26.3152 20368560
11. Cen P DA, Doshi D, Amato A phase I study of everolimus plus sorafenib in patients with metastatic renal cell carcinoma (mRCC). J Clin Oncol 27 2009:(suppl; abstr e16056).